108 related articles for article (PubMed ID: 1629294)
1. Quantification of distinct molecular species of the 2-lyso metabolite of platelet-activating factor by gas chromatography-negative-ion chemical ionization mass spectrometry.
Turk J; Bohrer A; Stump WT; Ramanadham S; Mangino MJ
J Chromatogr; 1992 Mar; 575(2):183-96. PubMed ID: 1629294
[TBL] [Abstract][Full Text] [Related]
2. Renal allograft platelet activating factor synthesis during acute cellular rejection.
Mangino MJ; Anderson CB; Murphy MK; Turk J
J Lipid Mediat; 1991; 4(1):69-81. PubMed ID: 1893087
[TBL] [Abstract][Full Text] [Related]
3. Determination of platelet-activating factor and alkyl-ether phospholipids by gas chromatography-mass spectrometry via direct derivatization.
Balazy M; Braquet P; Bazan NG
Anal Biochem; 1991 Jul; 196(1):1-10. PubMed ID: 1888023
[TBL] [Abstract][Full Text] [Related]
4. Analysis of lyso-platelet activating factor by negative ion gas chromatography/mass spectrometry of the nitrobenzal acetal derivatives.
Mallet AI
Biomed Environ Mass Spectrom; 1988 Oct; 16(1-12):207-10. PubMed ID: 3242671
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of lyso-platelet activating factor molecular species from human neutrophils by mass spectrometry.
Haroldsen PE; Clay KL; Murphy RC
J Lipid Res; 1987 Jan; 28(1):42-9. PubMed ID: 3104521
[TBL] [Abstract][Full Text] [Related]
6. Quantification of distinct molecular species of platelet activating factor in ulcerative colitis.
Thyssen E; Turk J; Bohrer A; Stenson WF
Lipids; 1996 Mar; 31 Suppl():S255-9. PubMed ID: 8729129
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
[TBL] [Abstract][Full Text] [Related]
8. Identification and quantitation of PAF from psoriatic scales.
Ramesha CS; Soter N; Pickett WC
Agents Actions; 1987 Aug; 21(3-4):382-3. PubMed ID: 3687590
[TBL] [Abstract][Full Text] [Related]
9. Nasal allergen challenge generates 1-0-hexadecyl-2-lyso-sn-glycero-3-phosphocholine.
Shin MH; Averill FJ; Hubbard WC; Chilton FH; Baroody FM; Liu MC; Naclerio RM
Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):660-6. PubMed ID: 8118633
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of platelet activating factor treated with pentafluorobenzoyl chloride using gas chromatography/negative ion chemical ionization mass spectrometry.
Shindo K; Hashimoto Y
Drugs Exp Clin Res; 1991; 17(7):343-9. PubMed ID: 1794300
[TBL] [Abstract][Full Text] [Related]
11. Measurement of sub-picogram quantities of platelet activating factor (AGEPC) by gas chromatography/negative ion chemical ionization mass spectrometry.
Ramesha CS; Pickett WC
Biomed Environ Mass Spectrom; 1986 Mar; 13(3):107-11. PubMed ID: 2938649
[TBL] [Abstract][Full Text] [Related]
12. Release of 1-O-alkylglyceryl 3-phosphorylcholine, O-deacetyl platelet-activating factor, from leukocytes: chemical ionization mass spectrometry of phospholipids.
Polonsky J; Tencé M; Varenne P; Das BC; Lunel J; Benveniste J
Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7019-23. PubMed ID: 6938950
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) and 1-alkyl-2-acetyl-sn-glycerol by human endothelial cells.
Blank ML; Spector AA; Kaduce TL; Lee TC; Snyder F
Biochim Biophys Acta; 1986 May; 876(3):373-8. PubMed ID: 3707974
[TBL] [Abstract][Full Text] [Related]
14. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain.
Tiberghien C; Laurent L; Junier MP; Dray F
J Lipid Mediat; 1991; 3(3):249-66. PubMed ID: 1773028
[TBL] [Abstract][Full Text] [Related]
15. Platelet activating factor, lyso-platelet activating factor and arachidonic acid release in normal human skin and the influence of topical steroid treatment.
Barr RM; Lawlor F; Judge MR; Courtney P; Barlow R; Kobza Black A; Mallet AI; Greaves MW
Br J Clin Pharmacol; 1993 Jun; 35(6):637-41. PubMed ID: 8329291
[TBL] [Abstract][Full Text] [Related]
16. Development of a high-performance liquid chromatographic-mass spectrometric technique, with an ionspray interface, for the determination of platelet-activating factor (PAF) and lyso-PAF in biological samples.
Silvestro L; Da Col R; Scappaticci E; Libertucci D; Biancone L; Camussi G
J Chromatogr; 1993 Sep; 647(2):261-9. PubMed ID: 8227267
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of platelet activating factor and metabolism of related lipids in embryonic cells.
Chepenik KP; Wykle RL
Biochim Biophys Acta; 1992 Jun; 1126(2):192-8. PubMed ID: 1627622
[TBL] [Abstract][Full Text] [Related]
18. MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities.
Baker RR; Chang H
Biochim Biophys Acta; 1998 Jun; 1392(2-3):351-60. PubMed ID: 9630721
[TBL] [Abstract][Full Text] [Related]
19. Characterization and quantification of PAF-acether (platelet-activating factor) as a heptafluorobutyrate derivative of 1-O-alkyl-2-acetyl-sn-glycerol by capillary column gas chromatography with electron-capture detection.
Bossant MJ; Farinotti R; Mencia-Huerta JM; Benveniste J; Mahuzier G
J Chromatogr; 1987 Dec; 423():23-31. PubMed ID: 3443654
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor in human normal tears.
Okumura N; Kojima K; Hashida M; Koura Y; Fukushima A; Ueno H
Curr Eye Res; 2005 Oct; 30(10):891-6. PubMed ID: 16251126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]